BlackRock Fund Advisors - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 25 filers reported holding CLEVELAND BIOLABS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q4 2016$1,0000.0%7410.0%0.00%
Q3 2016$1,000
-50.0%
741
+8.3%
0.00%
Q2 2016$2,0000.0%684
+10.3%
0.00%
Q1 2016$2,0000.0%620
+33.0%
0.00%
Q4 2015$2,0004660.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q4 2015
NameSharesValueWeighting ↓
B. Riley Wealth Advisors, Inc. 17,013$44,0000.00%
Renaissance Technologies 273,251$702,0000.00%
VANGUARD GROUP INC 52,592$135,0000.00%
IFP Advisors, Inc 150$00.00%
OSAIC HOLDINGS, INC. 290$1,0000.00%
BANK OF AMERICA CORP /DE/ 111$00.00%
WELLS FARGO & COMPANY/MN 457$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 17,598$45,0000.00%
MORGAN STANLEY 100$00.00%
View complete list of CLEVELAND BIOLABS INC shareholders